Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

No cure for female pattern hair loss, but various effective treatments exist.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Low iron and vitamin D levels are linked to hair loss in women.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Both mouse and rat models are effective for testing alopecia areata treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Higher iron levels in the blood are not linked to increased hair loss in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Prolactin slows down hair growth in mice.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.